US 11191763
HIV post-exposure prophylaxis
granted A61KA61K31/4418A61K31/47
Quick answer
US patent 11191763 (HIV post-exposure prophylaxis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/4418, A61K31/47, A61K31/513, A61K31/5377